Addex Therapeutics Ltd
ADXN | NASDAQ
$3.53
+$0.13 (+3.98%)
At close: Sep 21, 2026, 4:00 PM ET
$3.32
-$0.21 (-5.95%)
Pre-market:
Sep 22, 2026, 4:31 AM ET
Fiscal Quarter Period Ending | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 7.69K | 248 | 29.72K | 36.38K | n/a | 1.51K | 53.84K | 115.28K | 233.48K | 153.45K | 327.73K | 630.88K | 500.89K | 592.43K | 409.42K | 183.35K | 237.24K | 397.49K | 682K | 992.6K | 844.22K |
Cost of Revenue | 36.13K | n/a | n/a | 234.45K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -28.44K | 248 | 29.72K | -198.08K | n/a | 1.51K | 53.84K | 115.28K | 233.48K | 153.45K | 327.73K | 630.88K | 500.89K | 592.43K | 409.42K | 183.35K | 237.24K | 397.49K | 682K | 992.6K | 844.22K |
Operating Income | -479.83K | -779.26K | -696.18K | -732.9K | -606.26K | -445.63K | -622.2K | -899.32K | -788.09K | -2.68M | -749.24K | -396.18K | -367.66K | -3.5M | -4.17M | -7.09M | -5.76M | -4.28M | -3.58M | -4.51M | -3.15M |
Interest Income | n/a | n/a | n/a | 3 | n/a | -15 | 102 | 1.51K | 7.57K | 13.13K | 13.66K | 13.35K | 23.83K | 25.35K | 3.61K | 204 | 95 | 754 | 1.24K | 1.72K | 529.16K |
Pretax Income | -1.71M | -1.83M | -1.58M | -1.96M | -1.47M | -1.19M | -1.53M | -1.46M | -735.18K | -2.86M | -710.74K | -521.4K | -370.01K | -3.65M | -4.11M | -7.22M | -5.82M | -4.42M | -3.6M | -4.69M | -2.64M |
Net Income | -1.71M | -1.84M | -1.58M | -1.84M | -1.47M | -1.21M | -1.53M | 12.88M | -3.09M | -2.86M | -2.62M | -2.68M | -2.41M | -3.65M | -4.11M | -7.22M | -5.82M | -4.42M | -3.6M | -4.69M | -2.64M |
Selling & General & Admin | 389.32K | 567.98K | 459.92K | 411.96K | 448.07K | 260.57K | 337.25K | 507.17K | 571.74K | 1.7M | 473.99K | 593.04K | 504.75K | -240.68K | 2.39M | 2.1M | 3.05M | 497.58K | 2.05M | 1.85M | 1.32M |
Research & Development | 9.39K | 3.86K | 85.26K | 68.49K | 32.58K | -6.23K | 77.85K | 184.46K | 179.11K | 454.31K | 421.15K | 229.16K | 199.9K | 5.74M | 1.74M | 4.68M | 2.51M | 3.5M | 1.81M | 3.73M | 2.75M |
Other Expenses | 52.68K | 207.67K | 180.72K | 54.37K | 125.61K | 192.8K | 260.94K | 322.97K | 270.72K | 677.95K | 181.83K | 204.86K | 163.89K | -1.41M | 448.44K | 496.33K | 444.42K | 676.95K | 398.52K | -79.29K | -78.2K |
Operating Expenses | 451.39K | 779.51K | 725.9K | 534.82K | 606.26K | 447.13K | 676.04K | 1.01M | 1.02M | 2.84M | 1.08M | 1.03M | 868.55K | 4.09M | 4.58M | 7.28M | 6M | 4.67M | 4.26M | 5.5M | 3.99M |
Interest Expense | 3.07K | 575 | 472 | 829 | 548 | 1.49K | 586 | 864 | 611 | 8.36K | 3.5K | 3.83K | 609 | 7.77K | 6.38K | 12.33K | 22.41K | 9.34K | 9.99K | 22.94K | 20.74K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 487.52K | 779.51K | 725.9K | 769.27K | 606.26K | 447.13K | 676.04K | 1.01M | 1.02M | 2.84M | 1.08M | 1.03M | 868.55K | 4.09M | 4.58M | 7.28M | 6M | 4.67M | 4.26M | 5.5M | 3.99M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.43M | 1.19M | 938.98K | 721.04K | 819.54K | 815.2K | 812.79K | 812.79K | 812.79K | 793.64K | 643.99K | 601.57K | 510.41K | 497.46K | 398.21K | 312.23K | 315.79K | 289.81K | 284.35K | 283.83K | 279.33K |
Shares Outstanding (Diluted) | 1.43M | 1.19M | 938.98K | 767.15K | 819.54K | 815.2K | 812.79K | 812.79K | 812.79K | 793.64K | 643.99K | 601.57K | 510.41K | 497.46K | 398.21K | 312.23K | 315.79K | 289.81K | 284.35K | 283.83K | 279.33K |
EPS (Basic) | -1.20 | -1.54 | -1.67 | -2.56 | -1.80 | -1.48 | -1.88 | 15.60 | -3.80 | -3.60 | -4.07 | -4.45 | -4.72 | -7.34 | -10.32 | -22.80 | -18 | -15.60 | -13.20 | -16.80 | -9.44 |
EPS (Diluted) | -1.20 | -1.54 | -1.67 | -2.40 | -1.80 | -1.48 | -1.88 | 15.60 | -3.80 | -3.60 | -4.07 | -4.45 | -4.72 | -7.34 | -10.32 | -22.80 | -18 | -15.60 | -13.20 | -16.80 | -9.44 |
EBITDA | -1.7M | -1.83M | -1.57M | -1.96M | -1.47M | -1.16M | -1.47M | -1.34M | -664.21K | -2.77M | -634.82K | -445.32K | -293.62K | -3.57M | -4.02M | -7.13M | -5.71M | -4.33M | -3.5M | -4.58M | -2.53M |
EBIT | -1.71M | -1.83M | -1.58M | -1.96M | -1.47M | -1.19M | -1.53M | -1.46M | -734.57K | -2.85M | -710.2K | -520.73K | -369.4K | -3.64M | -4.1M | -7.21M | -5.8M | -4.41M | -3.59M | -4.67M | -2.62M |
Depreciation & Amortization | 9.82K | 2.12K | 2.12K | 2.12K | 2.12K | 23.8K | 53.58K | 112.38K | 70.36K | 79.39K | 75.38K | 75.41K | 75.78K | 75.65K | 77.32K | 83.35K | 86.83K | 82.97K | 87.74K | 88.26K | 88.65K |
Add to Watchlist
Select watchlists to add or remove ADXN